Legal & General Group
EWTX icon

Legal & General Group’s Edgewise Therapeutics EWTX Stock Holding History

Legal & General Group’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.34M Sell
42,537
-10,210
-19% -$294K ﹤0.01% 2047
2025
Q4 		$1.31M Sell
52,747
-3,194
-6% -$64.1K ﹤0.01% 2132
2025
Q3 		$907K Buy
55,941
+3,634
+7% +$51.5K ﹤0.01% 2269
2025
Q2 		$686K Buy
52,307
+1,959
+4% +$28.2K ﹤0.01% 2349
2025
Q1 		$1.11M Buy
50,348
+56
+0.1% +$1.47K ﹤0.01% 2151
2024
Q4 		$1.34M Buy
50,292
+6,635
+15% +$211K ﹤0.01% 2143
2024
Q3 		$1.17M Buy
43,657
+4,405
+11% +$87.6K ﹤0.01% 2181
2024
Q2 		$707K Buy
39,252
+10,761
+38% +$188K ﹤0.01% 2305
2024
Q1 		$520K Buy
28,491
+11,834
+71% +$188K ﹤0.01% 2410
2023
Q4 		$182K Buy
16,657
+13,127
+372% +$92.2K ﹤0.01% 2713
2023
Q3 		$20.2K Sell
3,530
-540
-13% -$3.67K ﹤0.01% 3022
2023
Q2 		$31.5K Buy
4,070
+436
+12% +$3.68K ﹤0.01% 2955
2023
Q1 		$24.2K Hold
3,634
– – ﹤0.01% 3016
2022
Q4 		$32.5K Buy
3,634
+1,060
+41% +$9.94K ﹤0.01% 3031
2022
Q3 		$25K Buy
2,574
+58
+2% +$586 ﹤0.01% 3147
2022
Q2 		$20K Sell
2,516
-2,122
-46% -$16K ﹤0.01% 3235
2022
Q1 		$44K Sell
4,638
-13
-0.3% -$167 ﹤0.01% 3021
2021
Q4 		$71K Buy
4,651
+2,786
+149% +$50.1K ﹤0.01% 2971
2021
Q3 		$31K Hold
1,865
– – ﹤0.01% 3113
2021
Q2 		$40K Buy
+1,865
New +$51K ﹤0.01% 3021

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Legal & General Group's EWTX Position: Q1 2026 in Review

Legal & General Group reduced its Edgewise Therapeutics (EWTX) stake by 19% in Q1 2026, selling an estimated $294K and leaving 42,537 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2047.

Legal & General Group first reported a position in EWTX in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.34M in Q4 2024. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Legal & General Group held 42,537 shares of Edgewise Therapeutics worth $1.34M as of Q1 2026.
  • Legal & General Group sold 10,210 Edgewise Therapeutics shares in Q1 2026, an estimated $294K.
  • Edgewise Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2047 holding.
  • Legal & General Group first reported a position in Edgewise Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Legal & General Group's Edgewise Therapeutics position peaked at $1.34M in Q4 2024.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.